Obesity and metabolic syndrome;Adipositas und metabolisches syndrom

Diabetologie und Stoffwechsel

Volumn 3, Issue 1, 2008, Pages

  Bluher M ^a,c   Hamann, A ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Diabetes Klinik Bad Nauheim   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; MOXONIDINE; NICOTINIC ACID; PIOGLITAZONE; PLACEBO; RAMIPRIL; RIMONABANT; ROSIGLITAZONE; SULFONYLUREA; TETRAHYDROLIPSTATIN;

BILIOPANCREATIC BYPASS; BODY MASS; DYSLIPIDEMIA; ENVIRONMENTAL FACTOR; GASTRECTOMY; HEREDITY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MEDITERRANEAN DIET; METABOLIC SYNDROME X; METEORISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PREVALENCE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; STEATORRHEA; STOMACH BYPASS;

EID: 52649131870     PISSN: 18619002     EISSN: 18619010     Source Type: Journal    
DOI: 10.1055/s-2008-1004703     Document Type: Review

References (21)

1. Hauner H, Buchholz G, Hamann A et al. Evidenzbasierte Leitlinie - Prävention und Therapie der Adipositas. Deutsche Adipositas-Gesellschaft, Deutsche Diabetes-Gesellschaft, Deutsche Gesellschaft für Ernährung, Deutsche Gesellschaft für Ernährungsmedizin (Hrsg.) 2007. www.adipositas-esellschaft.de
2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428
3. Blüher M, Stumvoll M. Metabolic syndrome - myths, mechanisms, management. Dtsch Med Wochenschr 2006; 131: 1167-1172
4. Hanefeld M, Leonhardt W. Das metabolische Syndrom. Dt Gesundheitswesen 1981; 36: 545-551
5. Mensink GB, Lampert T, Bergmann E. Übergewicht und Adipositas in Deutschland 1984-2003. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005; 48: 1348-1356
6. Wirth A, Hauner H. Das Metabolische Syndrom. München: Urban & Vogel 2007
7. Grundy SM, Cleeman JI, Daniels SR et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association /National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
8. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310-315
9. Hebebrand J, Friedel S, Schäuble N et al. Perspectives: molecular genetic research in human obesity. Obes Rev 2003; 4: 139-146
10. Frayling TM, Timpson NJ, Weedon MN et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 11: 316: 889-894
11. Shen BJ, Todaro JF, Niaura R et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 2003; 157: 701-711
12. Klöting N, Stumvoll M, Blüher M. The biology of visceral fat. Internist 2007; 48: 126-133
13. Engeli S. Role of the renin-angiotensin-aldosterone system in the metabolic syndrome. Contrib Nephrol 2006; 151: 122-134
14. Tuomilehto J, Lindstrom J, Eriksson JG et al Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350
15. Esposito K, Marfella R, Ciotola M et al. Effect of a mediterranean-style diet on endothelial dys-function and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 92: 1440-1446
16. Hamann A. Pharmakotherapie der Adipositas. Internist 2008 (im Druck)
17. Hamann A, Morcos M, Nawroth P. Diabetes mellitus Typ 2 - Medikamentöse Therapie. CME 2006; 3: 11-20
18. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865
19. Bosch J, Yusuf S, Gerstein HC et al. Effect of ramipril on the incidence of diabetes. N Engl J Med 2006; 355: 1551-1562
20. SjöströmL, Narbro K, Sjöström CD et al. Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752
21. Fachkommission Diabetes in Sachsen. Praxisleitlinie Metabolisch-Vaskuläres Syndrom. Dresden 2006. www.imib.med.tu-dresden.de/ diabetes